Applied Molecular Transpo... (AMTI)
Applied Molecular Transport Statistics
Share Statistics
Applied Molecular Transport has 41.85M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 41.85M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 31.86M |
| Failed to Deliver (FTD) Shares | 1.17K |
| FTD / Avg. Volume | 0.37% |
Short Selling Information
The latest short interest is 197.23K, so 0.47% of the outstanding shares have been sold short.
| Short Interest | 197.23K |
| Short % of Shares Out | 0.47% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.13 and the forward PE ratio is null. Applied Molecular Transport's PEG ratio is 0.
| PE Ratio | -0.13 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.27 |
| P/FCF Ratio | -0.17 |
| PEG Ratio | 0 |
Enterprise Valuation
Applied Molecular Transport has an Enterprise Value (EV) of -8.71M.
| EV / Sales | 0 |
| EV / EBITDA | 0.07 |
| EV / EBIT | 0.09 |
| EV / FCF | 0.09 |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.59.
| Current Ratio | 4.24 |
| Quick Ratio | 4.24 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | -0.28 |
| Debt / FCF | -0.37 |
| Interest Coverage | 40.67 |
Financial Efficiency
Return on Equity is -206.17% and Return on Invested Capital is -130.28%.
| Return on Equity | -206.17% |
| Return on Assets | -116.74% |
| Return on Invested Capital | -130.28% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-9.65M |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -894K |
| Effective Tax Rate | 0.71% |
Stock Price Statistics
The stock price has increased by -1.14% in the last 52 weeks. The beta is 2.29, so Applied Molecular Transport's price volatility has been higher than the market average.
| Beta | 2.29 |
| 52-Week Price Change | -1.14% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 62.9 |
| Average Volume (20 Days) | 320.19K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -127.22M |
| Net Income | -125.43M |
| EBITDA | -127.22M |
| EBIT | -129.45M |
| Earnings Per Share (EPS) | -3.23 |
Balance Sheet
The company has 61.15M in cash and 36.12M in debt, giving a net cash position of 25.02M.
| Cash & Cash Equivalents | 61.15M |
| Total Debt | 36.12M |
| Net Cash | 25.02M |
| Retained Earnings | -365.97M |
| Total Assets | 20.02M |
| Working Capital | 15.04M |
Cash Flow
In the last 12 months, operating cash flow was -93.9M and capital expenditures -4.15M, giving a free cash flow of -98.05M.
| Operating Cash Flow | -93.9M |
| Capital Expenditures | -4.15M |
| Free Cash Flow | -98.05M |
| FCF Per Share | -2.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -768.97% |
| FCF Yield | -601.12% |
Analyst Forecast
Currently there are no analyst rating for AMTI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -39.33 |
| Piotroski F-Score | 2 |